We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisers Recommend Approval of Pargluva
FDA Advisers Recommend Approval of Pargluva
September 16, 2005
A panel of FDA advisers has recommended approving the diabetes drug candidate Pargluva, which was co-developed by Bristol-Myers Squibb (BMS) and Merck, despite concerns over the product’s cardiovascular risks.